Search results
Johnson and Johnson Offers to Pay $6.5 Billion to Settle Talcum Powder Cancer Lawsuits
People via Yahoo Finance· 6 days agoJohnson and Johnson reiterated in its statement on Wednesday, May 1, that “none of the talc-related...
How Johnson & Johnson's $6.475 Billion Talc Settlement Impacts Black Women
Forbes· 1 day agoPharmaceutical giant Johnson & Johnson is set to pay $6.475 billion to settle lawsuits alleging its...
Johnson & Johnson offers $6.5 billion settlement in baby powder cancer lawsuits
KTVI via Yahoo News· 6 days agoJohnson & Johnson is offering to pay nearly six and a half billion dollars in a settlement deal. The...
Exclusive: Exclusive: In Tesla Autopilot probe, US prosecutors focus on securities, wire fraud
Reuters· 40 minutes ago, opens new tab committed securities or wire fraud by misleading investors and consumers about its...
Tom Brady telling off Jeff Ross was not scripted, Drew Bledsoe confirms
TheStreet.com· 2 days agoDuring Brady's roast, the NFL legend interrupted Ross after he made a joke after Robert Kraft. "The Roast of Tom Brady" was filled with a ton of laughs, even if the jokes would at times reach ...
A Look at Pharma ETFs Post Q1 Earnings
Zacks via Yahoo Finance· 22 hours agoLet’s delve deeper into the earnings of some of the bigwigs: Earnings in Focus Johnson and Johnson Johnson & Johnson JNJ continued with ...
Johnson & Johnson Highlights Commitment to Transform Treatment of Retinal Diseases at ARVO 2024
Char-Koosta News· 5 days agoCompany to present, across eight data presentations, new real-world research on the economic value...
Dewi Brown-DeVeaux’s crusade for equity, access and health care's future
Rolling Out· 7 days agoDewi Brown-DeVeaux, DNP, BS, RN-ONC is the senior director of nursing, patient engagement and...
Johnson & Johnson offers to pay $6.5 billion to settle talc ovarian cancer lawsuits - WDEF
WDEF Chattanooga· 6 days agoJohnson & Johnson said Wednesday it has offered to pay $6.5 billion to settle allegations that its...
Moderna’s sales from its only product, the COVID-19 vaccine, fell 91% from last year
Fortune via Yahoo Finance· 6 days agoOne reason for Moderna’s low sales is because Americans aren’t getting booster vaccines as...